Logo
Revanesse Kiss+ with Lidocaine (2 × 1.2 ml)

Revanesse Kiss+ with Lidocaine (2 × 1.2 ml)

Revanesse

Aesthetic injectable
  • Manufactured by Prollenium Medical Technologies Inc. under medical device quality standards; marketed as CE Marked hyaluronic acid dermal filler (non Medicinal injectable device).
  • Restricted to use by licensed medical professionals; sale or administration only under prescription/order by qualified practitioners.
  • Biodegradable and hyaluronidase Reversible — in case of adverse effect or unsatisfactory aesthetic outcome, filler may be dissolved under medical supervision.
Cross-linked hyaluronic acid dermal filler for lip enhancement

Description

Revanesse Kiss+ with Lidocaine is a sterile, cross-linked hyaluronic acid (HA) gel dermal filler designed for lip augmentation, contouring and perioral rejuvenation. The product uses proprietary Thixofix® cross-linking technology to deliver a smooth, malleable gel with optimal cohesivity and shape retention, providing natural-looking, soft lip volume and definition. It is supplied in a pack containing two prefilled 1.2 ml syringes plus sterile needles; the gel is intended for injection by qualified medical professionals only.

Bnefits

  • Specifically formulated for lip and perioral enhancement — volume, shape and definition with a natural feel.
  • Smooth, monophasic HA gel with high concentration and good cohesivity for even distribution and soft, natural results.
  • Includes lidocaine (0.3% w/w) to minimise injection pain and improve patient comfort.
  • Reduced risk of swelling and inflammation compared to some other fillers, due to smooth gel particles and optimized rheology.
  • Biocompatible, biodegradable HA-based filler that can be dissolved with hyaluronidase if needed.

Indications

  • Lip augmentation — increasing lip volume and enhancing lip shape and definition.
  • Perioral rejuvenation — smoothing fine lines around the mouth and relaxing ‘smoker’s lines’ / perioral wrinkles.
  • Volume correction or augmentation of lip vermilion and border, symmetry correction, and soft tissue enhancement in the perioral region.

Composition

  • Cross-linked hyaluronic acid (HA), non-animal origin, 25 mg/ml.
  • Lidocaine 0.3% w/w (approx. 3 mg/ml) for local anaesthesia during injection.
  • Buffered isotonic phosphate-buffered saline (PBS) carrier solution.
  • Cross-linking agent: 1,4-butanediol diglycidyl ether (BDDE) used to stabilise HA gel.

Formulation

  • Monophasic, cross-linked HA gel, sterile, viscoelastic, colourless and clear.
  • Supplied in sterile, single-use, prefilled disposable glass syringes (2 × 1.2 ml) with sterile needles (27G or 30G) included.

Packaging

  • Box containing two prefilled glass syringes of 1.2 ml HA gel each.
  • Includes two sterile 27G (or 30G) needles for immediate use.
  • Syringes are individually sealed in sterile trays/blisters; outer carton labelled with batch number, expiry date, product information and instructions for use.

Usage

  • Must be administered only by trained and licensed medical professionals experienced in facial injectable procedures.
  • Prior to injection, perform full medical history, informed consent and assessment of suitability, including risk of allergies to lidocaine or HA components.
  • Prepare and disinfect the injection site; attach a sterile 27G or 30G needle to syringe, expel air bubbles, and prime the filler carefully.
  • Inject into submucosal or superficial dermal layers of the lip vermilion or border, using small bolus or linear threading technique as per clinician’s standard of care for lip augmentation.
  • Massage gently after injection for even distribution if needed; avoid overcorrection.
  • Advise patient to follow post-treatment care: avoid makeup on treated area for recommended period, avoid intense heat or cold, strenuous exercise, alcohol or lip massage for 24–48 hours (or per clinician protocol).
  • Store unused syringes in original sealed packaging until use; do not reuse syringe or needle — single-use only.

Contraindications

  • Known hypersensitivity or allergy to hyaluronic acid, lidocaine or any filler components (e.g. BDDE or preservation agents).
  • Active infection, inflammation, open wounds, acne or other dermatological conditions on or near the injection site (e.g. perioral area, lips).
  • History of severe allergic or anaphylactic reactions to injectable fillers or local anaesthetics (amide-type).
  • Bleeding disorders, anticoagulant or antiplatelet therapy, or other conditions increasing bleeding risk, unless judged safe by clinician.
  • Pregnant or breastfeeding women (safety not established).
  • Patients under the legal age for aesthetic injectable treatments per local regulations (commonly under 18 or 21 depending on region).

Adverse Effects

  • Common, usually temporary injection-site reactions including redness, swelling, bruising, tenderness, pain, itching or mild discomfort.
  • Risk of lumps, nodules or unevenness if filler is over-injected or poorly distributed; may resolve spontaneously or require correction.
  • Allergic or hypersensitivity reactions to HA, lidocaine or other components, potentially including delayed inflammatory reactions or granuloma formation.
  • Infection if aseptic technique is not strictly followed or aftercare instructions are ignored.
  • Rare vascular complications (e.g. intravascular injection, occlusion, tissue ischaemia, necrosis) if injected incorrectly — especially in lip vascular anatomy.
  • Temporary numbness or altered sensation related to lidocaine or injection trauma, possibly transient.

Storage Conditions

  • Store unopened syringes at controlled room temperature as specified in product packaging (commonly between 2°C and 25°C); do not freeze.
  • Keep syringes in original sealed packaging, away from direct sunlight and extreme heat or cold, until use.
  • Use each syringe only once — dispose of any unused product, needles and syringes after treatment as per clinical waste regulations.
  • Do not use if outer packaging is damaged, seal is broken, product appears discoloured or contains particulate matter.

Duration

Effects typically last between 6 and 12 months, depending on patient metabolism, lifestyle and injection technique; some patients may seek touch-up or repeat treatments after this period.

Onset

Initial lip fullness and volume are visible immediately after injection; final settled result is generally apparent within 1\u20132 weeks as swelling subsides.

Browse more Aesthetic injectable

Top Treatments

Top Cities in the UK